Literature DB >> 385258

Cirrhotic hyperglobulinemia: increased rates of immunoglobulin synthesis by circulating lymphoid cells.

S R Berger, R A Helms, D M Bull.   

Abstract

We have measured immunoglobulin (Ig) synthesis by circulating lymphoid cells of 20 patients with cirrhotic hyperglobulinemia (CH) and 20 age-matched controls. We used specific anti-Ig antisera to precipitate Ig synthesized from [14C] amino acid precursors in 13 controls and employed an electroimmunoassay of the "rocket" type to measure Ig elaborated by cultured cells in 4 patient-control pairs. In addition, we studied 3 patient-control pairs by absorption of elaborated Ig onto an anti-Ig-coated solid phase, bromoacetylcellulose. The synthetic index (SI; the ratio of Ig synthesis by a CH patient and a control) was elevated in every case. Mean SI by coprecipitation was 7.2 +/- 5.4 (mean +/- SD), by rocket" 7.3 +/- 3.0 for IgG and 2.2 +/- 0.8 for IgA, and by immunoabsorption 13.8 +/- 8.4 for IgG. Three cirrhotic nonhyperglobulinemic patient-control pairs showed a mean SI of 1.0 +/- 0.1. CH and control populations showed equal numbers of membrane Ig-positive B lymphocytes by immunofluorescence. We conclude that (1) peripheral blood lymphoid cells are appropriate for study of differences in Ig synthetic capacity among individuals; (2) CH is associated with increased in vitro Ig synthesis; and (3) CH lymphocytes may be an appropriate cell population for the study of control mechanisms in Ig synthesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 385258     DOI: 10.1007/bf01317205

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  9 in total

1.  USE OF ANTIBODY BOUND TO MODIFIED CELLULOSE AS AN IMMUNOSPECIFIC ADSORBENT OF ANTIGENS.

Authors:  A T JAGENDORF; A PATCHORNIK; M SELA
Journal:  Biochim Biophys Acta       Date:  1963-11-15

2.  Biological expressions of lymphocyte activation. 3. Suppression of plaque-forming cell responses in vitro by supernatant fluids from concanavalin A-activated spleen cell cultures.

Authors:  R R Rich; C W Pierce
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

3.  Bacterial and dietary antibodies in liver disease.

Authors:  D R Triger; M H Alp; R Wright
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Increased jejunal immunoglobulin synthesis in patients with nontropical sprue as measured by a solid phase immunoadsorption technique.

Authors:  Z M Falchuk; W Strober
Journal:  J Lab Clin Med       Date:  1972-06

6.  Enhancement by irradiated T cells of human plasma cell production: dissection of helper and suppressor functions in vitro.

Authors:  F P Siegal; M Siegal
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

7.  A rapid electroimmunoassay system.

Authors:  D W Renn; E Evans
Journal:  Anal Biochem       Date:  1976-04       Impact factor: 3.365

8.  Immunoglobulins as cell receptors.

Authors:  B Pernis; L Forni; L Amante
Journal:  Ann N Y Acad Sci       Date:  1971-12-31       Impact factor: 5.691

9.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

  9 in total
  3 in total

1.  Polyclonal B cell activation in alcoholic patients with no evidence of liver dysfunction.

Authors:  P A Drew; P M Clifton; J T LaBrooy; D J Shearman
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

2.  Demonstration of non-specific B-cell stimulation in patients with cirrhosis.

Authors:  G Holdstock; W B Ershler; E L Krawitt
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

3.  Effect of mesentericocaval shunt upon globulin levels in the rat.

Authors:  G H Engelbrecht; R van Hoorn-Hickman; M Keraan; O L Meyers
Journal:  Dig Dis Sci       Date:  1981-12       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.